I'm looking forward to this next week:
"We have designed breast prototypes with our partners Establishment Labs (EL) garnering extensive input from surgeons around the globe. There is still work required, by EL, on the regulatory strategy and timeline. We will provide an in-market estimate with the mid-year results, February 2019. " (Annual Report, Nov. 2018)
- Forums
- ASX - By Stock
- PNV
- HY Report
HY Report
Featured News
Add PNV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.46 |
Change
0.000(0.00%) |
Mkt cap ! $1.695B |
Open | High | Low | Value | Volume |
$2.44 | $2.48 | $2.41 | $1.324M | 539.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
33 | 27395 | $2.45 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.47 | 21704 | 19 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
26 | 7458 | 2.460 |
32 | 35554 | 2.450 |
19 | 25105 | 2.440 |
14 | 26852 | 2.430 |
12 | 80314 | 2.420 |
Price($) | Vol. | No. |
---|---|---|
2.470 | 17926 | 24 |
2.480 | 76757 | 23 |
2.490 | 60827 | 16 |
2.500 | 31416 | 12 |
2.510 | 27508 | 6 |
Last trade - 14.49pm 28/08/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online